{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:33:03Z","timestamp":1792805583764,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012706","name":"University of Warmia and Mazury in Olsztyn","doi-asserted-by":"publisher","award":["15.610.008-110"],"award-info":[{"award-number":["15.610.008-110"]}],"id":[{"id":"10.13039\/501100012706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.dmd.2025.100213","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:26:53Z","timestamp":1765326413000},"page":"100213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["P-gp\/BCRP efflux and intestinal metabolism limit tigecycline exposure: Effects of elacridar and voriconazole in mice"],"prefix":"10.1016","volume":"54","author":[{"given":"Hubert","family":"Zi\u00f3\u0142kowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.dmd.2025.100213_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s002030050339","article-title":"Tetracyclines: antibiotic action, uptake, and resistance mechanisms","volume":"165","author":"Schnappinger","year":"1996","journal-title":"Arch Microbiol"},{"issue":"7","key":"10.1016\/j.dmd.2025.100213_bib2","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/AAC.37.7.1393","article-title":"Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples","volume":"37","author":"Nikaido","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.dmd.2025.100213_bib3","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/jps.2600581003","article-title":"pH-partition behavior of tetracyclines","volume":"58","author":"Colaizzi","year":"1969","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.dmd.2025.100213_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0022-5347(17)61269-2","article-title":"The passage of tetracyclines across epithelial membranes with special reference to prostatic epithelium","volume":"106","author":"Hessl","year":"1971","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.dmd.2025.100213_bib5","first-page":"625","article-title":"Drug diffusion and bioavailability: tetracycline metallic chelation","volume":"32","author":"Chin","year":"1975","journal-title":"Am J Hosp Pharm"},{"issue":"2","key":"10.1016\/j.dmd.2025.100213_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jac\/32.2.195","article-title":"The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli","volume":"32","author":"Mortimer","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"26","key":"10.1016\/j.dmd.2025.100213_bib7","doi-asserted-by":"crossref","first-page":"7655","DOI":"10.1021\/ja00520a003","article-title":"Chemical-structural properties of tetracycline derivatives. 7. Evidence for the coexistence of the zwitterionic and nonionized forms of the free base in solution","volume":"101","author":"Hughes","year":"1979","journal-title":"J Am Chem Soc"},{"issue":"2","key":"10.1016\/j.dmd.2025.100213_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"10.1016\/j.dmd.2025.100213_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/mr.60.4.575-608.1996","article-title":"Proton-dependent multidrug efflux systems","volume":"60","author":"Paulsen","year":"1996","journal-title":"Microbiol Rev"},{"issue":"4","key":"10.1016\/j.dmd.2025.100213_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0006-2952(00)00291-4","article-title":"Antibiotic efflux pumps","volume":"60","author":"Van Bambeke","year":"2000","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.dmd.2025.100213_bib11","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/jac\/dkg224","article-title":"Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy","volume":"51","author":"Van Bambeke","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.dmd.2025.100213_bib12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jac\/dkg225","article-title":"Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics","volume":"51","author":"Van Bambeke","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.dmd.2025.100213_bib13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1471-4159.2007.04772.x","article-title":"Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier","volume":"103","author":"Milane","year":"2007","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.dmd.2025.100213_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2885.2007.00808.x","article-title":"P-glycoprotein-mediated transport of oxytetracycline in the Caco-2 cell model","volume":"30","author":"Schrickx","year":"2007","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100213_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2023.100493","article-title":"Bioavailability of tetracyclines is substantially increased by administration of cyclosporine A, a non-specific efflux-pump blocker","volume":"50","author":"Zi\u00f3\u0142kowski","year":"2023","journal-title":"Drug Metab Pharmacokinet"},{"issue":"6","key":"10.1016\/j.dmd.2025.100213_bib16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jac\/dkl403","article-title":"Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose","volume":"58","author":"Rodvold","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.dmd.2025.100213_bib17","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1016\/j.psj.2020.06.038","article-title":"Comparative pharmacokinetics of chlortetracycline, tetracycline, minocycline, and tigecycline in broiler chickens","volume":"99","author":"Zi\u00f3\u0142kowski","year":"2020","journal-title":"Poult Sci"},{"issue":"4","key":"10.1016\/j.dmd.2025.100213_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1124\/dmd.113.055590","article-title":"Use of cassette dosing approach to examine the effects of P-glycoprotein on the brain and cerebrospinal fluid concentrations in wild-type and P-glycoprotein knockout rats","volume":"42","author":"Liu","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.dmd.2025.100213_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118638","article-title":"Validation of a P-glycoprotein (P-gp) humanized mouse model by integrating selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with in vivo functional analysis for blood-brain barrier transport","volume":"10","author":"Sadiq","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.dmd.2025.100213_bib20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/AAC.01123-08","article-title":"Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A","volume":"53","author":"Jeong","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.dmd.2025.100213_bib21","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1128\/AAC.02931-15","article-title":"Inhibitory potential of antifungal drugs on ATP-binding cassette transporters P-glycoprotein, MRP1 to MRP5, BCRP, and BSEP","volume":"60","author":"Lempers","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.dmd.2025.100213_bib22","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1124\/dmd.112.045930","article-title":"Brain distribution and bioavailability of elacridar after different routes of administration in the mouse","volume":"40","author":"Sane","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1016\/j.dmd.2025.100213_bib23","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1128\/AAC.47.10.3165-3169.2003","article-title":"In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model","volume":"47","author":"Andes","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.dmd.2025.100213_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1515\/pjvs-2017-0029","article-title":"Determination of tigecycline in turkey plasma by LC-MS\/MS: validation and application in a pharmacokinetic study","volume":"20","author":"Jasiecka-Miko\u0142ajczyk","year":"2017","journal-title":"Pol J Vet Sci"},{"issue":"15","key":"10.1016\/j.dmd.2025.100213_bib25","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.3390\/molecules26154437","article-title":"Development, validation, and application of the LC-MS\/MS method for determination of 4-acetamidobenzoic acid in pharmacokinetic pilot studies in pigs","volume":"26","author":"Markowska","year":"2021","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.dmd.2025.100213_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/bmc.3616","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS\/MS) method for the quantification of tigecycline in rat brain tissues","volume":"30","author":"Munyeza","year":"2016","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.dmd.2025.100213_bib27","series-title":"A tutorial with R, JAGS, and Stan","article-title":"Doing Bayesian data analysis","author":"Kruschke","year":"2015"},{"issue":"7","key":"10.1016\/j.dmd.2025.100213_bib28","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/oik.05985","article-title":"Moving beyond noninformative priors: why and how to choose weakly informative priors in Bayesian analyses","volume":"128","author":"Lemoine","year":"2019","journal-title":"Oikos"},{"key":"10.1016\/j.dmd.2025.100213_bib29","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.3389\/fpsyg.2019.02767","article-title":"Indices of effect existence and significance in the Bayesian framework","volume":"10","author":"Makowski","year":"2019","journal-title":"Front Psychol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100213_bib30","first-page":"189","article-title":"Why we (usually) don\u2019t have to worry about multiple comparisons","volume":"5","author":"Gelman","year":"2012","journal-title":"J Res Educ Eff"},{"issue":"1","key":"10.1016\/j.dmd.2025.100213_bib31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3758\/s13423-016-1221-4","article-title":"The Bayesian New Statistics: hypothesis testing, estimation, meta-analysis, and power analysis from a Bayesian perspective","volume":"25","author":"Kruschke","year":"2018","journal-title":"Psychon Bull Rev"},{"issue":"4","key":"10.1016\/j.dmd.2025.100213_bib32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/jvp.13433","article-title":"Bayesian estimation in veterinary pharmacology: a conceptual and practical introduction","volume":"47","author":"Woodward","year":"2024","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100213_bib33","year":"2024"},{"key":"10.1016\/j.dmd.2025.100213_bib34","series-title":"rstanarm: Bayesian applied regression modeling via Stan [computer program]. Version 2.32.1","author":"Goodrich","year":"2024"},{"key":"10.1016\/j.dmd.2025.100213_bib35","series-title":"tidybayes: tidy data and geoms for Bayesian models [computer program]","author":"Kay","year":"2024"},{"issue":"5","key":"10.1016\/j.dmd.2025.100213_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v052.i05","article-title":"Fast and elegant numerical linear algebra using the RcppEigen package","volume":"52","author":"Bates","year":"2013","journal-title":"J Stat Soft"},{"issue":"2","key":"10.1016\/j.dmd.2025.100213_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/10543406.2016.1265543","article-title":"Bioequivalence evaluation of sparse sampling pharmacokinetics data using bootstrap resampling method","volume":"27","author":"Shen","year":"2017","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.dmd.2025.100213_bib38","series-title":"resample: resampling functions [computer program]. Version 0.6","author":"Hesterberg","year":"2022"},{"issue":"3","key":"10.1016\/j.dmd.2025.100213_bib39","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s11095-012-0918-y","article-title":"Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: application of PBPK modeling in the assessment of drug-drug interaction potential","volume":"30","author":"Gertz","year":"2013","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.dmd.2025.100213_bib40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/dmd.113.054932","article-title":"Cytochrome P450 inhibitory properties of common efflux transporter inhibitors","volume":"42","author":"Englund","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.dmd.2025.100213_bib41","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1124\/dmd.120.090621","article-title":"Strain-dependent variability of early discovery small molecule pharmacokinetics in mice: does strain matter?","volume":"48","author":"Barr","year":"2020","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.dmd.2025.100213_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra020021","article-title":"Inheritance and drug response","volume":"348","author":"Weinshilboum","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.dmd.2025.100213_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1258\/002367785780890712","article-title":"A comparison of subcutaneous and intraperitoneal oxytetracycline injection methods for control of infectious disease in the rat","volume":"19","author":"Porter","year":"1985","journal-title":"Lab Anim"},{"issue":"1","key":"10.1016\/j.dmd.2025.100213_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","article-title":"Intraperitoneal route of drug administration: should it be used in experimental animal studies?","volume":"37","author":"Al Shoyaib","year":"2019","journal-title":"Pharm Res"},{"issue":"9","key":"10.1016\/j.dmd.2025.100213_bib45","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1124\/dmd.107.015735","article-title":"Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects","volume":"35","author":"Hoffmann","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmd.2025.100213_bib46","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.104.068288","volume":"310","author":"Ward","year":"2004","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625095224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625095224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:59:06Z","timestamp":1777474746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625095224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0090955625095224"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100213","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P-gp\/BCRP efflux and intestinal metabolism limit tigecycline exposure: Effects of elacridar and voriconazole in mice","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100213"}}